Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Tridax procumbens has medicinal properties.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Microneedles with green tea polyphenols improve diabetic wound healing.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Tofacitinib is effective and safe for treating alopecia areata.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Fucoidan-derived carbon dots can effectively treat root canal infections by killing bacteria and are safer than traditional disinfectants.

Tridax procumbens is a versatile herb with many health benefits.

Tofacitinib, a hair regrowth treatment, may worsen acne.

The hydrogel speeds up healing of normal and MRSA-infected wounds.

Baricitinib was effective in treating both early and late onset alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

A woman developed lupus after taking hydroxyurea for two years.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.